Aurora Cannabis (ACB) Interest Coverage Ratio (2017 - 2026)
Aurora Cannabis (ACB) posted quarterly Interest Coverage Ratio of 2.26 for Q1 2026, down 90.59% year-on-year from 23.98 in Q1 2025, and down 90.59% on a QoQ basis from 23.98 in Q1 2025.
Aurora Cannabis (ACB) Interest Coverage Ratio (2017 - 2026) Analysis & Trends
Aurora Cannabis (ACB) has reported Interest Coverage Ratio for 9 consecutive years, with 2.26 the latest figure, recorded in Q1 2026.
- Quarterly Interest Coverage Ratio fell 90.59% year-over-year to 2.26 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 14.23 (up 357.27% YoY) and the FY2026 annual result came in at 9.93, down 1083.18% from the prior year.
- Interest Coverage Ratio slipped to 2.26 in Q1 2026 per ACB's latest filing, from 23.98 in the prior quarter.
- Over the last five years, Interest Coverage Ratio for ACB reached as high as 23.98 in Q1 2025 and fell as low as 29.51 in Q1 2022.
- A 4-year average of 1.14 and a median of 0.56 in 2024 frame the typical range for Interest Coverage Ratio.
- Annual changes were most pronounced in 2022 — Interest Coverage Ratio soared 38.26% — and 2026, when it plunged 90.59%.
- Year by year, Interest Coverage Ratio stood at 5.77 in 2022, then soared by 423.53% to 18.65 in 2024, then increased by 28.57% to 23.98 in 2025, then tumbled by 90.59% to 2.26 in 2026.
- According to Business Quant data, Interest Coverage Ratio over the past three periods registered 2.26, 23.98, and 18.65 for Q1 2026, Q1 2025, and Q4 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 13.44 |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -2.81 |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 0.18 |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -0.07 |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 0.33 |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 5.11 |
| 10 | Aurora Cannabis | 1.11 Bn | 1.03 Bn | 21.72 Mn | 2.26 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.26 |
| Mar 31, 2025 | 23.98 |
| Dec 31, 2024 | 18.65 |
| Sep 30, 2024 | -1.10 |
| Jun 30, 2024 | -0.56 |
| Jun 30, 2022 | -5.77 |
| Mar 31, 2022 | -29.51 |
| Dec 31, 2021 | -3.90 |
| Sep 30, 2021 | -2.57 |
| Jun 30, 2021 | -3.16 |
| Mar 31, 2021 | -47.80 |
| Dec 31, 2020 | 315.76 |
| Sep 30, 2020 | -2.89 |
| Jun 30, 2020 | -16.59 |
| Mar 31, 2020 | 12.42 |
| Dec 31, 2019 | 11.20 |
| Sep 30, 2019 | -75.00 |
| Jun 30, 2019 | 144.43 |
| Mar 31, 2019 | 5.55 |
| Dec 31, 2018 | 27.00 |